Abstract:Left atrial appendage occlusion (LAAO) is an established stroke prevention strategy in carefully selected patients with nonvalvular atrial fibrillation. There are two commercially available LAAO devices in the United States-Watchman FLX (Boston Scientific) and Amulet Device (Abbott). Since its Food and Drug Administration (FDA) approval in the United States in March 2015, more than 100,000 patients have undergone LAAO with watchman device. In addition, the FDA approved the Amulet LAAO device in August 2021 and… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.